Session Abstract – PMWC 2023 Silicon Valley
The PMWC 2023 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.
Confirmed Presenting Companies:
Speaker Profile
Ph.D., Director of Digital Health, Astellas Pharma, Inc
Biography
Dr. Jin Lee is the Director of Digital Health at Astellas Pharma Inc. She focuses on new product development and commercialization globally. Dr. Lee formerly worked at the innovation centers and venture arms of Humana and Providence St. Joseph Health. She also co-founded and worked in multiple startups in the maternal/ child, education, and restaurant space.
Based in Silicon Valley, Dr. Lee advises and invests in multiple digital health startups and accelerator programs. She also serves on multiple nonprofit boards, including the American Heart Association and the Healthcare Businesswomen’s Association.
Dr. Lee is a Presidential Leadership Scholar (selected by four American presidential centers) and has been a featured speaker at multiple events such as the TEDxPeacePlaza, Sirius XM radio, SXSW, American Academy of Pediatrics, and Aspen Institute Childrens Forum. She received her Ph.D in Neuropsychology from the University of Oxford and BA in Biology and Neuroscience from the University of Pennsylvania.
Talk
Health Monitoring Showcase:
Astellas Pharma, Inc
Astellas aims to contribute and provide VALUE to patients in various ways, not limited to treatment with drugs but across the whole patient journey (overall medical care, including diagnostic, preventive, therapeutic and prognostic care). We refer to this non-pharma activity as our Rx+® businesses.
Orchana: there's a better way to experience Menopause
Astellas' Rx+ BA is developing a digital platform to help menopausal women learn and manage their symptoms.
Speaker Profile
Ph.D., R&D Manager, DNAGenotek/Novosanis
Biography
Brice Le François currently leads the technology research teams at DNA Genotek (microbiome devices) and Diversigen (microbiome services) as a Senior R&D manager. He obtained his Ph.D. in Biochemistry from the University of Ottawa and has over 20 years of experience in research across a wide range of fields, including cancer and neuroscience. Since joining the R&D team at DNA Genotek, he has worked extensively on optimizing the stabilization and processing of human microbiome samples. His team spearheaded the development of novel tools and workflows for low biomass samples as well as novel DNA/RNA stabilization chemistries that enable multi-omics analyses of gut microbiome samples and beyond.
Talk
Health Monitoring Showcase:
DNAGenotek/Novosanis
Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Design Of Self-Sampling First-Void Urine Collection Method
Different Colli-Pee® volume variants are explored, while maintaining sample quality and respecting urine-to-preservative ratio.
Speaker Profile
Ph.D., Senior Scientist, QIAGEN
Biography
Oezlem Karalay obtained M.Sc. degree in Neuroscience from MPI for Developmental Biology, Tubingen. She received her doctorate in Neuroscience from the Swiss Federal Institute of Technology (ETH), Zurich. She joined QIAGEN after completion of her postdoctoral research at the MPI for Biology of Ageing, Cologne, and since then has been involved in developing the digital PCR assay portfolio, including mutation detection and CNV assays.
Talk
Health Monitoring Showcase:
QIAGEN
QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins. We deliver Sample to Insight solutions for molecular testing, propelling our customers from start to finish to unlock new insights.
Detection of rare events in liquid biopsy samples using QIAcuity Digital PCR system
“Detection of rare events in liquid biopsy samples using QIAcuity Digital PCR system”
